Welcome to BioSeeker Group!

The Complete Guide to Targeted Therapies in Oncology: A World Review

Additional Information

Published Date Dec 19, 2006
Pages 550
PDF Fact Sheet View Fact Sheet for the report The Complete Guide to Targeted Therapies in Oncology: A World Review in PDF
Format PDF
Publisher BioSeeker Group

Availability: In stock

$4,950.00

Quick Overview

In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to The Complete Guide to Targeted Therapies in Oncology: A World Review.

    To find out more about The Complete Guide to Targeted Therapies in Oncology: A World Review, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that The Complete Guide to Targeted Therapies in Oncology: A World Review is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Introduction

The dogma for treatment of cancer has changed, with the cytotoxic drugs used in chemotherapy regimes set to lose their dominance and be used alongside targeted therapies that are being developed with the aim of more specifically targeting cancer cells.

Research and analysis highlights

In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology.
This extensive 550+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the mentioned key oncology targeted therapy areas. The report will not only provide a framework but also a careful identification and evaluation of drug candidates, technologies and competitors.
The number of targeted therapy drugs has risen sharply, as have the number of targets. The fiercest competition in oncology targeted therapy is pointed out and how several big pharma companies are out hunting for promising technology and drugs to complement their internal pipeline.

Scope of this report

  • In-depth competitive landscape assessment of the targeted oncology market place; Including more than 340 drugs and pharmaceutical companies
  • Thorough review of six major targeting strategies in oncology: Apoptopic agents, Protein kinase inhibitors, Anti-angiogenic and vascular targeting agents, Immunostimulators, Antibodies and Vaccines
  • Progress analysis of major cancer indications for respective targeting strategy, including players, drugs, clinical progress and pitfalls
  • Includes more than 120 Tables, 60 Boxes and close to 40 Figures

Key reasons to read this report

  • Understand the clinical and strategic challenges to the commercialization of six major targeting strategies in oncology
  • Assess opportunities and risks for the continued development of targeting agents in major cancer indications.
  • Adopt knowledge from this analysis to drive strategic planning decisions in oncology drug development

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to The Complete Guide to Targeted Therapies in Oncology: A World Review.
    To find out more about The Complete Guide to Targeted Therapies in Oncology: A World Review, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that The Complete Guide to Targeted Therapies in Oncology: A World Review is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Other selected research from the 'Oncology' category:


Triple Analysis: Breast Cancer, Apoptosis and Angiogenesis
This triple analysis focuses on cancer drug development strategies in Breast Cancer and by the two mechanism/target/effect areas of Apoptosis and Angiogenesis. Learn More


Triple Analysis: Pancreatic Cancer, Antibodies and Peptides
This triple analysis focuses on cancer drug development strategies in Pancreatic Cancer and by the two compound strategies of Antibodies and Peptides. Learn More

Other selected research from the 'Vaccines' category:


Cancer Vaccines: Aim and Shoot
This report aims to analyze the current and future potential of cancer vaccines by examining key fundamentals across the entire pipeline of cancer vaccine drug candidates. Learn More


The Complete Guide to Targeted Therapies in Oncology: A World Review
In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies and vaccines in oncology. Learn More

Other selected research from the 'Targeted' category:


Target Atlas in Oncology Drug Development: Targeted Therapies
This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. Learn More


Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology
Assess opportunities and risks for the continued development of anti-angiogenic and vascular targeting agents in five major cancer indications. Learn More